MedPath

Effect of prophylactic supplementation of sodium on prevention of late onset sodium deficiency in neonates less than 32 weeks - A double blinded placebo randomised control trial

Phase 3
Registration Number
CTRI/2024/05/066608
Lead Sponsor
Dr Amrutha Visalakshi S
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Preterm Neonates less than 32 weeks of gestation admitted within 7 days of life at NICU of ABVIMS and Dr. RML Hospital, New Delhi with Serum sodium 130-145 mEq/L by postnatal day 4

Exclusion Criteria

Presence of lethal congenital malformations or chromosomal abnormalities

Presence of AKI (defined as an S. Creatinine rise more than or equal to0.3 mg/dl within 48 h or urine output less than 0.5 (ml/kg/h) for 6–12 h)

Disease states (such as hydrops fetalis) that are characterized by edema- like hydrops fetalis, congestive heart failure within DOL 7

Refusal to consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath